The abstract spells it out: "This suggests fundamental differences in these treatments’ therapeutic actions, with SSRIs mitigating negative emotions and psilocy

The abstract spells it out: "This suggests fundamental differences in these treatments’ therapeutic actions, with SSRIs mitigating negative emotions and psilocybin allowing patients to confront and work through them. Based on the present results, we propose that psilocybin with psychological support is a treatment approach that potentially revives emotional responsiveness in depression, enabling patients to reconnect with their emotions."